Allergies News and Research

Latest Allergies News and Research

New chromosomal abnormality in acute lymphoblastic leukemia

Researchers identified a new chromosomal abnormality in acute lymphoblastic leukemia (ALL) that appears to work in concert with another mutation to give rise to cancer. This latest anomaly is particularly common in children with Down syndrome.

19 Oct 2009

Leahy's funds help physicians and independent pharmacies to adopt health information technology

More Vermont physicians will be using electronic prescribing and other health information technology to improve patient care, under a $1 million federal grant secured by U.S. Senator Patrick Leahy.

19 Oct 2009

Phase I clinical study of PENNVAX-B preventive DNA vaccine using electroporation technology

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, and the HIV Vaccine Trials Network (HVTN) announced today the initiation of a phase I clinical study of Inovio’s PENNVAX-B preventive DNA vaccine delivered using its proprietary electroporation technology.

19 Oct 2009

Cost saving benefit faces eventual elimination without relief

Despite Speaker Nancy Pelosi's (D-Calif.) support of President Obama's pledge not to raise taxes on the middle class, the House of Representatives is now considering -- outside of the normal legislative process -- adopting provisions approved yesterday by the Senate Finance Committee that would drastically restrict the use of flexible spending accounts (FSAs) in order to help pay for health care reform.

15 Oct 2009

UT Southwestern Medical Center awarded $15.7M NIH contract to develop a new virus database

The National Institutes of Health has awarded a $15.7 million contract to UT Southwestern Medical Center and Northrop Grumman Corp. to develop an open-access national online database and analysis resource center that will help scientists study and combat viruses such as those that cause hepatitis, encephalitis, smallpox, acute respiratory distress and dengue fever, as well as newly emerging pathogenic viruses.

15 Oct 2009

Cytheris initiates Phase I/IIa dose escalation study of patients suffering from ICL

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa dose escalation study of patients suffering from idiopathic CD4 lymphocytopenia (ICL).

15 Oct 2009

ACS to develop and maintain the Kentucky Health Information Exchange

Affiliated Computer Services, Inc., today announced that it has been awarded a contract that will help improve the quality of healthcare in Kentucky by providing physicians with a more complete picture of a patient’s medical history.

14 Oct 2009

NIBIB awards $1M grant to develop a rapid test for sepsis-related pathogens

Smiths Detection today announces the award of a $1m, two-year grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to develop a rapid test for eight micro-organisms that commonly cause burn/wound infections leading to septicemia (blood-poisoning).

14 Oct 2009

Harvard researchers unite in fight against antibiotic resistance

The National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) have awarded $5 million to an interdisciplinary group of Harvard researchers to launch the "Harvard-wide Program on Antibiotic Resistance."

14 Oct 2009

NIH awards Novavax a SBIR grant for respiratory syncytial virus vaccine research

Novavax, Inc. announced today that it has received a Small Business and Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The grant from the NIAID is to support a segment of the Company's preclinical research program for the respiratory syncytial virus (RSV) particle-based vaccine.

14 Oct 2009

NanoBio to receive a $4.1M subcontract for developing nanoemulsion-based mucosal vaccine adjuvants

NanoBio Corporation today announced an award from the National Institute of Allergy and Infectious Diseases, a Division of The National Institute of Health, to fund vaccine research associated with “Innate Immune Receptors and Adjuvant Discovery.” NanoBio is the principal subcontractor for the $9.3 million contract awarded to the University of Michigan.

14 Oct 2009

NIH awards $2.2m grant to Smiths Detection to develop a test for multiple types of influenza

Smiths Detection today announces the award of a $2.2m, two-year grant from the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health (NIH), to develop a test for multiple types of influenza.

14 Oct 2009

Sequella receives Phase 1 SBIR grant for developing SQ641

Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it received a $594,661 two-year Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) for the development of SQ641, Sequella's lead compound in its capuramycin series, a new class of antibiotic.

13 Oct 2009

Exhibitors display latest biotechnology products and applications at BIOTECHNICA 2009

Chalking up an increase in the number of exhibitors and trade visitors plus the amount of display space sold, the BIOTECHNICA, exhibition (6 to 8 October 2009) sent some important signals in the midst of an economic crisis.

13 Oct 2009

NIH funds the University of California's consortium for immune disorder research

The University of California, San Francisco has been designated to lead a new consortium that will study a group of severe immune disorders known as primary immunodeficiencies and aims to improve treatment for these often life-threatening diseases. The Primary Immune Deficiency Treatment Consortium comprises 13 centers throughout the United States and has a $6.25 million funding commitment over five years from the National Institutes of Health.

13 Oct 2009

Wake Forest University School of Medicine honours researchers

Wake Forest University School of Medicine honored eight of its researchers with awards for excellence at the 13th Annual Research Awards Day Oct. 1.

12 Oct 2009

Public forum and scientific workshop on women's health issues

The Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital will host a public forum and scientific workshop Oct. 14 to 16 to discuss emerging issues of importance for the National Institutes of Health (NIH) for women's health research in the coming decade.

12 Oct 2009

NIH to launch 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women, children and youth

The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week.

12 Oct 2009

NIH launches trial for the determination of 2009 H1N1 influenza vaccine for asthma patients

The National Institutes of Health is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease.

12 Oct 2009

Aspen Institute and TIME magazine to present panel discussions on health care reform

With health care reform headed to the floor of the House and Senate, the Aspen Institute and TIME magazine will present a day of panel discussions designed to shed light on what the looming changes will mean for the American people.

9 Oct 2009

Allergies News and Research

Latest Allergies News and Research

New chromosomal abnormality in acute lymphoblastic leukemia

Leahy's funds help physicians and independent pharmacies to adopt health information technology

Phase I clinical study of PENNVAX-B preventive DNA vaccine using electroporation technology

Cost saving benefit faces eventual elimination without relief

UT Southwestern Medical Center awarded $15.7M NIH contract to develop a new virus database

Cytheris initiates Phase I/IIa dose escalation study of patients suffering from ICL

ACS to develop and maintain the Kentucky Health Information Exchange

NIBIB awards $1M grant to develop a rapid test for sepsis-related pathogens

Harvard researchers unite in fight against antibiotic resistance

NIH awards Novavax a SBIR grant for respiratory syncytial virus vaccine research

NanoBio to receive a $4.1M subcontract for developing nanoemulsion-based mucosal vaccine adjuvants

NIH awards $2.2m grant to Smiths Detection to develop a test for multiple types of influenza

Sequella receives Phase 1 SBIR grant for developing SQ641

Exhibitors display latest biotechnology products and applications at BIOTECHNICA 2009

NIH funds the University of California's consortium for immune disorder research

Wake Forest University School of Medicine honours researchers

Public forum and scientific workshop on women's health issues

NIH to launch 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women, children and youth

NIH launches trial for the determination of 2009 H1N1 influenza vaccine for asthma patients

Aspen Institute and TIME magazine to present panel discussions on health care reform

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in